AAAAI Studying Asthma Medication Safety in Pregnant Women

  • Posted on: 16 August 2011
  • By: lsweetman

The AAAAI is coordinating the Vaccines and Medications in Pregnancy Surveillance System (VAMPSS), a comprehensive system to study the safety of medications and vaccines in pregnancy. One of its federally funded studies is focused on the safety of long- and short-acting beta agonist medications in pregnancy. One arm of VAMPSS depends on referrals of pregnant women with asthma who are still in the first half of pregnancy.

To make the study successful, VAMPSS is looking to recruit 400 pregnant asthmatic women in the next year who reside anywhere in the U.S. or Canada and who are willing to participate in a telephone interview based study. The prospective surveillance arm of VAMPSS is being conducted through the Organization of Teratology Information Specialists (OTIS), and their staff can provide you with information and answer any questions you may have. For more information, contact the OTIS study coordinating center at the University of California San Diego at (877) 311-8972 or email d4johnson@ucsd.edu